Compounds that modulate endothelin activity

Details Compounds that modulate endothelin activity Compounds that modulate endothelin activity

1994-01-12

1996-08-06

Berch, Mark L.

Organic compounds -- part of the class 532-570 series

Organic compounds

Nitrogen attached directly or indirectly to the purine ring...

544244, 546200, 546201, 548532, 548533, C07D48704, C07D20716, A61K 31495

Patent

active

055435211

ABSTRACT:
Compounds of formula (I) and pharmaceutical compositions containing the compounds of formula (I): ##STR1## are provided. In formula (I): Ar is a substituted or unsubstituted aromatic or heterocyclic group; R is H or a substituted or unsubstituted straight or branched chain, cyclic or mixture of straight branched and cyclic alkyl, alkenyl, or alkynyl group having from 1-20 carbon atom; A is a functional group that bears a polar moiety; R.sub.1 is R, R--C=0, R substituted with one or more heteroatoms, a substituted or unsubstituted aryl group, or is aryl-(CH.sub.2).sub.n ; R.sub.2 is (CH.sub.2).sub.n, CHR, C(R).sub.2, COO, OCO, NHCO, CONH, SO, SO.sub.2 or NR; R.sub.3 and R.sub.4, which are the same or different or each may be absent, and are .dbd.O, H, O-aryl, OR, O-alkyl or alkyl, aryl, SR, S-aryl, NHR, NH-aryl, NR, or are other heteroaromatic groups; R.sub.5 is H, OH or R; E and F, which are the same or are different, are either N or (CH.sub.2).sub.p ; p is an integer or 0 between 0 and 5; m and n are integers or 0 between 0 and 10; T is O, S, NCOR or NR; U and V, which may be the same or different, are (CH.sub.2)n; W is CO, (CH.sub.2)n, (CH.sub.2).sub.n --CHR or CHR--(CH.sub.2).sub.n ; X and Y, which may be the same or different, are H, alkyl or aryl or X and Y form a saturated or unsaturated homocyclic or heterocyclic ring contain 3-15 members; and Z is H, SR, NHR or N(R).sub.2.

REFERENCES:
patent: 3920660 (1975-11-01), Fontanella
patent: 4997836 (1991-05-01), Sugihara et al.
patent: 5082838 (1992-01-01), Naka
patent: 5114918 (1992-05-01), Ishikawa
patent: 5187195 (1993-02-01), Oohata
patent: 5198548 (1993-03-01), Beylin
patent: 5230999 (1993-07-01), Suzuki
patent: 5231166 (1993-07-01), Masaki et al.
patent: 5240910 (1993-08-01), Lam
patent: 5248807 (1993-09-01), Fujimoto
patent: 5334598 (1984-08-01), Bagley
Clozel I, Nature 365, 759 (Oct. 1993).
Clozel II, J. Cardiovasc. Pharmacology 22(Suppl 8) 5377 (1993).
Mihara, Eur. J. Pharmacology--Molec. Pharmacology Section 246, 33-38 (1993).
"Third Int. Conf. on Endothelin" Feb. 15-17, 1993, Abstracts, pp. 98, 19, 15, 37.
Benigni, Kidney Int. 44, 440 (1993).
Nirei, Life Sci 52, 1869-1874 (1993).
Chemical Abstracts vol. 106 1987, Abst. 33114a, Simazaki et al. Jpn. Kokai Tokkyo Koho JP 61,112,060, Piperazine derivatives.
Doherty, "Endothelin: A new challenge," J. Medicinal Chem., 35(9):1493-1508 (1992).
Bolger et al., "Characterization of binding of the Ca.sup.++ channel antagonist [.sup.3 H] nitrendipine, to guinea-pig ileal smooth muscle," J. of Pharmacology and Experimental Therapeutics, 225:291-309 (1983).
Williams et al., "Sarafotoxin S6c: An agonist which distinguishes between endothelin receptor subtypes," Biochem. and Biophys. Research Commun., 175(2):556-561 (1991).
Ihara et al., "An endothelin receptor (ET.sub.A) antagonist isolated from Streptomyces Misakiensis," Biochem. and Biophys. Research Commun., 178(1):132-137 (1991).
Spinella et al., "Design and synthesis of a specific endothelin 1 antagonist: Effects on pulmonary vasoconstriction," Proc. Natl. Acad. Sci. USA, 88p:7443-7446 (1991).
Saeki et al., "[Ala.sup.1,3,11,15 ] endothelin-1 analogs with ET.sub.B agonistic activity," Biochem. and Biophys. Research Commun., 179(1):286-292 (1991).
Gu et al., "The inhibitory effect of [D-Arg.sup.1, D-Phe, D-Try.sup.7,9, Leu.sup.11 ] substance P on endothelin-1 binding sites in rat cardiac membranes," Biochem. and Biophys. Research Commun., 179(1):130-133 (1991).
Panek et al., "Endothelin and structurally related analogs distinguish between endothelin receptor subtypes," Biochem. and Biophys. Research Commun., 183(2):566-571 (1992).
Ihara et al., "Biological profiles of highly potent novel endothelin antagonists selective for the ET.sub.A receptor," Life Sciences, 50:247-255 (1991).
Hirata et al., "Receptor binding activity and cytosolic free calcium response by synthetic endothelin analogs in culture rat vascular smooth muscle cells," Biochem. and Biophys. Research Commun., 160:228-234 (1989).
Nakajima et al., "Synthesis of endothelin-1 analogues, endothelin-3, and sarafotoxin S6b: Structure-activity relationships," J. of Cardiovascular Pharm., 13(Suppl. 5):S8-S12 (1989).
Yanagisawa et al., "A novel potent vasoconstrictor peptide produced by vascular endothelial cells," Nature, 332:411-415 (1988).
Kashiwabara et al., "Putative precursors of endothelin have less vasoconstrictor activity in vitro but a potent pressor effect in vivo," FEBS Letters, 247(1):73-76 (1989).
von Geldern et al., "A fluorogenic assay for endothelin-converting enzyme," Peptide Research, 4(1):32-35 (1991).
Inoue et al., "The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes," Proc. Natl. Acad. Sci. USA, 86:2863-2867 (1989).
Saida et al., "A novel peptide, vasoactive intestinal contractor, of a new (endothelin) peptide family," J. Biol. Chem., 264(25):14613-14616 (1989).
Brooks et al., "Effect of nifedipine on cyclosporine A-induced nephrotoxicity, urinary endothelin excretion and renal endothelin receptor number," Eur. J. of Pharmacology, 194:115-117 (1991).
Bolger et al., "Vascular reactivity, tissue levels, and binding sites for endothelin: A comparison in the spontaneously hypertensive and Wistar-Kyoto rats," Can. J. Physiol. Pharm., 69:406-413 (1990).
Simonson et al., "Endothelin-1 stimulates contraction of rat glomerular mesangial cells and potentiaties .beta.-Adrenergic-mediated cyclic adenosine monophosphate accumulation," J. Clin. Invest., 85:790-797 (1990).
Stewart et al., "Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease?" Annals of Internal Medicine, 114(6):464-469 (1991).
Takayanagi et al., "Presence of non-selective type of endothelin receptor on vascular endothelium and its linkage to vasodilation," FEBS Letters, 282(1):103-106 (1991).
Nishikori et al., "Receptor binding affinity and biological activity of C-terminal elongated forms of endothelin-1," Neurochem. Int., 18(4):535-539 (1991).
Castiglione et al., "Alanine scan of endothelin," Peptides: Chemistry and Biology, Proc. Amer. Rept. Symp. (Twelfth), J. A. Smith and J. E. Rivier, Eds., ESCOM, Leiden, 1992, pp. 402-403.
Galantino et al., "D-Amino acid scan of endothelin," Peptides: Chemistry & Biology, Proc. Amer. Report. Symp. (Twelfth), J. A. Smith and J. E. Rivier, Eds., ESCOM, Leiden, 1992, pp. 404-405.
Filep et al., "Endothelin-1 induces prostacyclin release from bovine aortic endothelial cells," Biochem. and Biophys. Research Comm., 177(1):171-176 (1991).
Spokes et al., "Studies with endothelin-3 and endothelin-1 on rat blood pressure and isolated tissues: Evidence for multiple endothelin receptor subtypes," J. of Cardiovascular Pharmacology, 13(Suppl. 5):S191-S192 (1989).
Cardell et al., "Two functional endothelin receptors in guinea-pig pulmonary arteries," Neurochem. Int., 18(4):571-574 (1991).
Borges et al., "Tissue selectivity of endothelin," Eur. J. of Pharmacology, 165:223-230 (1989).
Ogawa et al., "Molecular cloning of a non-isopeptide-selective human endothelin receptor," Biochem. and Biophys. Research Comm., 178(1):248-255 (1991).
Schvartz et al., "Bovine cerebellum endothelin receptor: Solubilization and identification," Endocrinology, 126(6):23218-3222 (1990).
Saudek et al, "Solution conformation of endothelin-1 by .sup.1 H NMR, CD, and molecular modeling," Int. J. Peptide Protein Res., 37:174-179 (1991).
Aumelas et al., "Determination of the structure of [Nle.sup.7 ]-endothelin by .sup.1 H NMR," Int. J. Peptide Protein Res., 37:315-324 (1991).
Perkins et al., "Proposed solution structure of endothelin," Int. J. Peptide Protein Res., 36:128-133 (1990).
Spinella et al., "A proposed structural model of endothelin," Peptide Research, 2(4):286-291 (1989).
Saudek et al., ".sup.1 H-NMR study of endothelin, sequence-specific assignment of the spectrum and a solution structure," FEBS Letters, 257(1):145-148 (1989).

Affiliated with

Also associated with

Rating

Compounds that modulate endothelin activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds that modulate endothelin activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds that modulate endothelin activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2191997